Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Double-dummy, Sucralfate Controlled, Multicenter Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis

NCT01284647 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT01284647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01284647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Double-dummy, Sucralfate Controlled, Multicenter Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis
Lead sponsor
Changhai Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2011
Completion date
June 30, 2013
Enrollment
156 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic erosive gastritis